Current Oncology Reports

Chemotherapy-induced peripheral neuropathy: An increasing concern for oncologists

Maurie Markman

Web alert

First-line therapy for advanced colorectal cancer

Aimery de Gramont, Christophe Tournigand, Christophe Louvet, Frédérique Maindrault-Goebel, Thierry André

Second-line therapy for advanced colorectal carcinoma

Naureen Starling, David Cunningham

Adjuvant therapy for colon cancer

Weijing Sun, Daniel G. Haller

Chemotherapy for advanced pancreatic cancer: Past, present, and future

Gregory Friberg, Hedy Lee Kindler

Chemoradiotherapy for gastrointestinal cancers

Tyvin A. Rich, Christopher Crane, Joshua D. Lawson, Jerome Landry

Docetaxel-based chemotherapy trials in androgen-independent prostate cancer: First demonstration of a survival benefit

Daniel P. Petrylak

Adjuvant chemotherapy for transitional cell carcinoma of the bladder: Paradigms for the design of clinical trials

Michelle Boyar, Daniel P. Petrylak

Angiogenesis and prostate cancer: Important laboratory and clinical findings

Michael C. Cox, Matthew Permenter, William D. Figg

Chemotherapy for advanced prostate cancer: Results of new clinical trials and future studies

Andrew J. Armstrong, Michael A. Carducci

Secondary hormonal manipulations in prostate cancer

Charles J. Ryan, Eric J. Small